Price $3.36 |
Market Cap
64.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.49
|
P/S
2.35
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-5.2K
|
FCF
-0.3
|
|
Op. Margin
-29.20%
|
Net Margin
-29.60%
|
ROE
-29.70%
|
ROI
-40.00%
|
|
ROA
-19.80%
|
EPS Growth
76.20%
|
Current Ratio
1.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Vycor Medical Inc (VYCO) | $0.30 | - | - | 3.8M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.59 | - | - | 4.8M | Strong Buy |
| Invo Bioscience Inc (IVOB) | $0.23 | - | - | 31.1M | Strong Buy |
| Enzon Pharmaceuticals Inc (ENZN) | $0.39 | - | - | 17.2M | Strong Buy |
| Endo International PLC (ENDP) | $8.38 | - | - | 2.49B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
